A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Clinical trial NCT00967330 · COMPLETED

Trial details

NCT number: NCT00967330
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2010-06-01
Primary completion: 2014-09-01
Enrollment: 182

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.